Relmada Therapeutics
RLMD
RLMD
109 hedge funds and large institutions have $66.6M invested in Relmada Therapeutics in 2022 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 29 increasing their positions, 34 reducing their positions, and 57 closing their positions.
Holders
109
Holders Change
-25
Holders Change %
-18.66%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
34
Increased
29
Reduced
34
Closed
57
Calls
$7.39M
Puts
$1.67M
Net Calls
+$5.72M
Net Calls Change
+$87.3M
Top Buyers
| 1 |
DTC
1
Deep Track Capital
Greenwich,
Connecticut
|
$9.9M |
| 2 |
2
Acadian Asset Management
Boston,
Massachusetts
|
$3.83M |
| 3 |
3
Millennium Management
New York
|
$3.71M |
| 4 |
4
Two Sigma Investments
New York
|
$1.84M |
| 5 |
5
Walleye Capital
New York
|
$1.65M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
176
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
|
XS
177
XR Securities
Chicago,
Illinois
| – | – | – | – |
|
|
CM
178
Caption Management
Oklahoma City,
Oklahoma
| – | – | – | – |
|